CAMBRIDGE, Mass. (AP) _ Bluebird Bio Inc. (BLUE) on Wednesday reported a loss of $68.7 million in its first quarter.
The Cambridge, Massachusetts-based company said it had a loss of $1.68 per share.
The results surpassed Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for a loss of $1.72 per share.
The biotechnology company posted revenue of $6.8 million in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $1.5 million.
Bluebird shares have risen 41 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $87.25, more than doubling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLUE at https://www.zacks.com/ap/BLUE
Keywords: Bluebird Bio, Earnings Report